Fri, Jan 30, 2015, 5:28 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Amarantus Bioscience Holdings, Inc Message Board

  • csense777 csense777 Jul 26, 2014 7:15 PM Flag

    Well well well I see the pumping

     

    On all the Yahoo boards has finally paid off for a few. In case anyone doesn't know this company is pumped day and night. Looks like some newbies fell for it.

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • How dare they fall for the price going up. Did you mean short newbies

    • CATALYSTS COMING IN THE NEAR FUTURE:
      LymPro Data
      LymPro Revenue Guidance
      LymPro Partnership Announcement
      MANF/Retinitis Functionality Data
      MANF/Retinitis Break Through, Fast Track, Orphan Designation
      MANF/Wolframs/Diabetes Data
      MANF/Wolframs Break Through, Fast Track, Orphan Designation
      Gerald uses Partnership Money to do a Stock Buy Back
      Gerald's LymPro Media Blitz in November
      Up Listing to NASDAQ in November
      LymPro Commercialization in November
      Institutional Investors Taking Positions after Up List
      Eltoprazine Starts Phase 2b Clinical Trial
      MANF/Retinitis Partnership in Q1 2015
      MANF/Wolframs/Diabetes Partnership in Q1 2015
      Phenoguard New Discoveries
      AMBS spins off the Diagnostic Division (Creating shareholder value)
      More MANF indications
      Pumper????????
      Buy loser

    • We all know YMB is the place where smart investors make there trading decisions. Lol.

    • Too bad you didn't buy when it was .08, sucks to be you.

    • Thanks for the heads up, I will make all my decisions based on what you say LOL

    • Yeah, it's been pumped day and night for the last 20 months. You know what that means? It is a company that is growing and becoming known as having supernova potential as a ten bagger+++. People like to invest in companies that are going somewhere. So, yeah, a 20 month pump with milestones being met and pipeline being furthered to the point of commercialization. The secret's out.

      • 1 Reply to zarconimous
      • Only one thing, not to bash your story, but all the milestones were not met on time.
        It was a PR flurry that saved the company, the only two things keeping it afloat are
        Lincoln Park Capital and Lympro Release of data, what a joke. if you have the data
        release it right? Release the data, this stock and its management are working the
        system as best they can trying hard to stay in the boundaries of legal statements
        while pumping the hell out of the stock in many ways all is OK with what is going on.
        But one thing really stinks, the continual propagation of re-stated information. That is just fine but after a few of these releases, I question management as to why not just release the Core information
        about you products as soon as possible. I was long I'm gone. It only takes a click of a mouse to be long again. Cash is king with money runners in the game now its just a matter of time before it crashes
        %30 again. Or more. Like the company over-all like the plan don't like the delay in formation
        the delay in truth being released.

        How does a .10-1.7 stock go to 2.00 uplisting over-night.they should release information
        that is
        "public" and not hold back at all.

    • Pumped day and night? Not sure about that one... I get around the YMB's and I've only seen it two other place so far, the SPY board of all places by a chartist there, and I did see AMBS on the Puma mb after their spike last week, but I saw dozens of other posts about dozens of other microcap biotechs... par for the course frankly. Do you have a position here?

 
AMBS
0.0815-0.0002(-0.24%)Jan 30 3:59 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.